Off-target effects in CRISPR/Cas9 gene editing

被引:147
|
作者
Guo, Congting [1 ,2 ]
Ma, Xiaoteng [3 ]
Gao, Fei [3 ]
Guo, Yuxuan [1 ,2 ,4 ,5 ]
机构
[1] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China
[2] Peking Univ, Inst Cardiovasc Sci, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China
[4] Minist Educ Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China
[5] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
off-target effects; gene editing; CRISPR/Cas9; gene therapy; Cas9/sgRNA complex; GENOME-WIDE ANALYSIS; DOUBLE-STRANDED BREAKS; CRISPR-CAS9; NUCLEASES; UNBIASED DETECTION; HUMAN-CELLS; CAS9; DNA; SEQ; DELIVERY; BASE;
D O I
10.3389/fbioe.2023.1143157
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Gene editing stands for the methods to precisely make changes to a specific nucleic acid sequence. With the recent development of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, gene editing has become efficient, convenient and programmable, leading to promising translational studies and clinical trials for both genetic and non-genetic diseases. A major concern in the applications of the CRISPR/Cas9 system is about its off-target effects, namely the deposition of unexpected, unwanted, or even adverse alterations to the genome. To date, many methods have been developed to nominate or detect the off-target sites of CRISPR/Cas9, which laid the basis for the successful upgrades of CRISPR/Cas9 derivatives with enhanced precision. In this review, we summarize these technological advancements and discuss about the current challenges in the management of off-target effects for future gene therapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Heritable multiplex gene editing via CRISPR/Cas9 exhibits no detectable genome-wide off-target effects in sheep.
    Wang, X.
    Chen, Y.
    JOURNAL OF ANIMAL SCIENCE, 2016, 94 : 177 - 177
  • [32] Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment
    Merlin, J. P. Jose
    Abrahamse, Heidi
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [33] Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
    Kimberland, Michelle L.
    Hou, Wangfang
    Alfonso-Pecchio, Adolfo
    Wilson, Stephen
    Rao, Yanhua
    Zhang, Shu
    Lu, Quinn
    JOURNAL OF BIOTECHNOLOGY, 2018, 284 : 91 - 101
  • [34] Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants
    Hajiahmadi, Zahra
    Movahedi, Ali
    Wei, Hui
    Li, Dawei
    Orooji, Yasin
    Ruan, Honghua
    Zhuge, Qiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (15)
  • [35] Crispr-SGRU: Prediction of CRISPR/Cas9 Off-Target Activities with Mismatches and Indels Using Stacked BiGRU
    Zhang, Guishan
    Luo, Ye
    Xie, Huanzeng
    Dai, Zhiming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [36] Recognition of CRISPR/Cas9 off-target sites through ensemble learning of uneven mismatch distributions
    Peng, Hui
    Zheng, Yi
    Zhao, Zhixun
    Liu, Tao
    Li, Jinyan
    BIOINFORMATICS, 2018, 34 (17) : 757 - 765
  • [37] Beyond precision: evaluation of off-target clustered regularly interspaced short palindromic repeats/Cas9-mediated genome editing
    Pena-Gutierrez, Irene
    Olalla-Sastre, Beatriz
    Rio, Paula
    Rodriguez-Madoz, Juan R.
    CYTOTHERAPY, 2025, 27 (03) : 279 - 286
  • [38] Mathematical and computational analysis of CRISPR Cas9 sgRNA off-target homologies
    Zhou, Michael
    Li, Daisy
    Huan, Xiaoli
    Manthey, Joseph
    Lioutikova, Ekaterina
    Zhou, Hong
    INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2017, 10 (06)
  • [39] Assessing Off-Target Editing of CRISPR-Cas9 Systems
    Pruett-Miller, Shondra M.
    CRISPR JOURNAL, 2020, 3 (06): : 430 - 432
  • [40] Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
    Sinclair, Frazer
    Begum, Anjuman A.
    Dai, Charles C.
    Toth, Istvan
    Moyle, Peter M.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (5) : 1500 - 1519